We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEG
3251
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$4K ﹤0.01%
954
-17,033
-95% -$49.3K
ATTU
3252
DELISTED
Attunity Ltd
ATTU
$4K ﹤0.01%
160
+152
+1,900% +$3.39K
AKBA icon
3253
Akebia Therapeutics
AKBA
$252M
$3K ﹤0.01%
388
-114
-23% -$782
ALKS icon
3254
Alkermes
ALKS
$8.25B
$3K ﹤0.01%
+83
New +$2.74K
APPS icon
3255
Digital Turbine
APPS
$1.74B
$3K ﹤0.01%
935
-10,052
-91% -$27.6K
ASC icon
3256
Ardmore Shipping
ASC
$683M
$3K ﹤0.01%
435
-1,308
-75% -$7.18K
ATRA icon
3257
Atara Biotherapeutics
ATRA
$76.1M
$3K ﹤0.01%
3
AVNW icon
3258
Aviat Networks
AVNW
$273M
$3K ﹤0.01%
426
-4,100
-91% -$28.8K
AWRE icon
3259
Aware
AWRE
$27.7M
$3K ﹤0.01%
+701
New +$2.6K
BAH icon
3260
Booz Allen Hamilton
BAH
$9.15B
$3K ﹤0.01%
60
-1,560
-96% -$81K
BANX
3261
ArrowMark Financial
BANX
$199M
$3K ﹤0.01%
157
-40
-20% -$827
BCRX icon
3262
BioCryst Pharmaceuticals
BCRX
$2.4B
$3K ﹤0.01%
+353
New +$3.02K
BLBD icon
3263
Blue Bird Corp
BLBD
$2.18B
$3K ﹤0.01%
+172
New +$3.23K
BRF icon
3264
VanEck Brazil Small-Cap ETF
BRF
$21.4M
$3K ﹤0.01%
144
+101
+235% +$2.24K
BSVN icon
3265
Bank7 Corp
BSVN
$481M
$3K ﹤0.01%
184
-1,319
-88% -$20.8K
CLAR icon
3266
Clarus
CLAR
$143M
$3K ﹤0.01%
244
-835
-77% -$9.41K
CLPS icon
3267
CLPS Inc
CLPS
$25.7M
$3K ﹤0.01%
300
-2,130
-88% -$18.8K
CMTL icon
3268
Comtech Telecommunications
CMTL
$51.8M
$3K ﹤0.01%
+138
New +$3.42K
COKE icon
3269
Coca-Cola Consolidated
COKE
$12.8B
$3K ﹤0.01%
+90
New +$2.06K
CVGI icon
3270
Commercial Vehicle Group
CVGI
$147M
$3K ﹤0.01%
387
-2,013
-84% -$15.1K
CYBR
3271
DELISTED
CyberArk
CYBR
$3K ﹤0.01%
+27
New +$2.58K
DK icon
3272
Delek US
DK
$3.58B
$3K ﹤0.01%
91
-421
-82% -$14.3K
DUST icon
3273
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$50.7M
0
DXLG icon
3274
Destination XL Group
DXLG
$35.4M
$3K ﹤0.01%
1,198
-5,638
-82% -$14.1K
EBND icon
3275
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$3K ﹤0.01%
100

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.